management of cancer of cervix

Management Dilemmas in Cervical Cancer

Prof. Surendra Nath Panda, M.S.

Dept. of Obstetrics and Gynecology

M.K.C.G.Medical College

Berhampur, Orissa, India

04:17 AM 04:17 AM

Management Dilemmas in Cervical Cancer- Prof. S.N.Panda 202-11-02

Cervical Cancer

• 500,000 new cases identified each year• 80% of the new cases occur in developing

countries• At least 200,000 women die of cervical cancer

each year • Cervical cancer is the third most common

cancer worldwide• YET - Cervical cancer is a preventable disease

Magnitude of the Problem: -

Please see notes page.

04:17 AM 04:17 AM


Cervical CancerIncidence and Death in relation to detection of CISIncidence and Death in relation to detection of CIS

*Please see notes page..

04:17 AM 04:17 AM


Cervical Cancer

• Symptoms: -– Asymptomatic in early cases/ preclinical stage– Haemorrhage- Metrorrhagia / Post coital.

• Bleeding is usually severe in cauliflower like exophytic growths.

– Discharge- watery, offensive, blood stained– Cachexia and Pain-In advanced cases.

Clinical Features: -

04:17 AM 04:17 AM


Cervical Cancer

• Signs: -– An obvious growth may or may not be present– When an obvious growth is present, it may be

exophytic cauliflower like or endophytic, ulcerative and scirrhous

– Cervix is usually indurated and hard to feel, friable, easily bleeds on touch and its mobility may be restricted or lost.

– In cases of endocervical growths, the Cx is expanded, firm and feels barrel shaped.

Clinical Features: -

04:17 AM 04:17 AM


Cervical Cancer

• PAP smear examination• Colposcopy• Biopsy: -

– Excisional biopsy is preferable to punch biopsy– Employing Schiller’s test / Acetic acid test helps in

selecting the biopsy site where the growth is not obvious.

– Cone biopsy in early cases

• Endocervical curettage

Diagnosis: -

04:17 AM 04:17 AM


Cervical Cancer

• Squamous Cell (>90%)

• Adenocarcinoma (5%)

• Clear Cell

• Mesonephric

Histopathology

04:17 AM 04:17 AM


Cervical Cancer

• 0:Carcinoma-in-situ• Ia:Microinvasive (Ia1, Ia2)• Ib:Invasive (>5mm FIGO, >3mm SGO)• IIa:Upper 2/3 of vagina• IIb:Parametrial involvement (not to PSW)• IIIa:Lower 1/3 of vagina• IIIb:PSW or hydronephrosis/nonfunctional kidney• IVa:Bladder or rectal mucosa• IVb:Distant metastases

Staging: -Always Clinical

04:17 AM 04:17 AM


• Complete physical Exam, Pelvic Exam , Rectal Exam.– if needed, examination under anaesthesia, should be done.

• Ultrasonography• Chest X ray• IVP• Cystoscopy• Proctosigmoidoscopy

Staging: -Techniques

Cervical Cancer

04:17 AM 04:17 AM


Cervical Cancer

SURGERY RADIOTHERAPY

THE TREATMENT DILEMMATHE TREATMENT DILEMMA

04:17 AM 04:17 AM


Treatment of Cervical Cancer

• Stage I A-I. (<1mm).– Conization– Simple Hysterectomy -- vaginal / abdominal– Type I Hysterectomy (Extra fascial)

• Stage I A-II. (1 – 3mm, Lymph node - 1%).– Type II Hysterectomy (Modified radical

Hysterectomy-Removal of medial half of uterosacral and cardinal ligaments and smaller margin of vagina)

Options: -

04:17 AM 04:17 AM



• Stage I B & II A.– Type III Hysterectomy (Radical hysterectomy with

removal of most of utero sacral and cardinal ligaments, upper 1/3 rd of vagina, pelvic lymphadenectomy) followed by

– Post operative irradiation

• Bulky Lesions & stage II B– Full irradiation followed 3 - 4 weeks later by– Type II Hysterectomy

Options: -

04:17 AM 04:17 AM



• Recurrent disease: -as per previous treatment– RT Exenteration– Surgery RT

• Stage III & IV: - Radiation / ??Exenteration

• Radiation, as primary treatment is an option in all stages.

• Chemotherapy - as adjunct to RT or for palliation

Options: -

04:17 AM 04:17 AM


Radical Hysterectomy

• Removes corpus, cervix, parametria, upper third of vagina

• Uterine arteries divided at origin

• Ureters dissected through tunnel

• Uterosacral ligaments divided near rectum

• Typically combined with LND

• Oophorectomy not mandatory

Key Points: -

04:17 AM 04:17 AM



• Abdominal exploration• Assessment of operability• Ligation and section of ovario pelvic fold and round

ligament• Dissection of pelvic lymphnodes• Dissection of ureter• Separation of bladder• Ligation of uterine vessels

Technique: -

04:17 AM 04:17 AM



• Dissection of ureter from cardinal ligament

• Cleaning of paravescial and pararectal fossa

• Opening of rectovaginal septum

• Clamping and transection of uterosacral and cardinal ligament

• Transection of vagina

• Hemostasis and drainage

• Reperitonisation

Technique: -

04:17 AM 04:17 AM



• Acute: Hemorrhage, Trauma, Sepsis, Thrombophlebitis, Pulmonary Embolism, Small Bowel obstruction, Febrile Morbidity, UVF - 1-2%, V V F - < 1%,

• Primary mortality- 1%

• Sub Acute: Neurogenic bladder dysfunction

• ChronicLymphocyst, Ureteral stricture

Complications: -

04:17 AM 04:17 AM



• More thorough assessment of the spread and type of lesion

• ? Preservation of ovaries if desired• Retention of more functional vagina• Less morbidity and less recurrence• Special conditions like

– Large Adnexal masses– Fibromyoma– Radioresistatnt growth– Unsuitable for intracavitary irradiation– Central recurrence after radiotherapy

Advantages: -

04:17 AM 04:17 AM


Schauta Operation

• Adopted as Mitra’s Operation In India as an alternative to Wertheim’s Hysterectomy.

• Its an extended Vaginal Hysterectomy.• Comprises of removal of entire Uterus and

Adenexae with most of the vagina and medial portion of parametria, by vaginal route

• Though primary mortality is low (<1%) lymph nodes cannot be removed. So it should be followed by– Post operative radiation or

– Taussig’s extra peritoneal Lymphadenectomy

An Alternative surgery: -

04:17 AM 04:17 AM


Radiation

Acute: -• Perforation• Fever• Diarrhea• Bladder spasm

Chronic: -• Proctitis• Cystitis-UTI• Fistula• Enteritis• Femoral head necrosis• Ureteric stenosis• Rectal stricture

Complications: -

04:17 AM 04:17 AM


Special Category

• Invasive Cancer discovered on Cone Biopsy

• Cervical Stump Carcinoma

• Invasive Carcinoma found after simple hysterectomy

• Cervical Cancer in Pregnancy

• Large Barrel shaped lesion

Difficult to deal: -

04:17 AM 04:17 AM


Follow Up

• At 2-3 Months interval ---- 2year

• At 3-4 Months interval ---- Next 2- 4 year

• At 6 Monthly interval ----- Rest of the life

• ?Tumour markers

04:17 AM 04:17 AM


Cervical Cancer

0

20

40

60

80

100

%

IA IB IIA IIB III

Stage

SCCAAdenoCA

from Grigsby, P.W., et.al Radiother Oncol 12:289, 1988from Grigsby, P.W., et.al Radiother Oncol 12:289, 1988

Five-Year Survival: -

Please see notes page.

04:17 AM 04:17 AM


Conclusion

• “Prophylaxis - better than cure” - Never more True• Pre treatment evaluation and Proper staging is a must.• Surgery and radiation are complimentary. So proper

team is essential- Surgeon and Radiotherapist should join hands.

• Stage for stage, little progress has been made in lowering mortality rates.

• However, the overall mortality rate is decreasing because more patients are having their cancers diagnosed in early states of disease.

04:17 AM 04:17 AM


Conclusion

• Five year survival - stage IA – 100 %, IB - 85 - 90 % , stage IIA- 70 - 75 %

• Many physicians are discouraged with the results of cancer therapy.

• However, the opportunity is there for all physicians to make an early diagnosis in Ca Cx and to protect the women from this dreadful disease.

• Those women saved from the ravages of cervical cancer shall call their physicians blessed.

04:17 AM 04:17 AM


Conclusion

“Days are gone when a patient with gynaecological malignancy could be

treated by a surgeon or a radiotherapist in isolation”. -Stallworthy

04:17 AM 04:17 AM


Thank YouThank You

At the service of women

management of cancer of cervix

Documents

Transcript of management of cancer of cervix